Company profile
Integrated Cannabis Solutions, Inc.
OTC: IGPK · Healthcare · Drug Manufacturers - Specialty & Generic
#1163 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ 19GM —SS 45
v0.1 · 25/100 weight · pillars only
↑ listing tenure, Altman-Z · ↓ workforce scale, disclosure history
Methodology →Revenue TTM
$86.7M
Rev growth YoY (TTM)
+88.5%
Net income (FY)
-$373.9k
Employees
1
as of 2026-09-25
Market cap
$8.6M
as of 2026-09-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02021
Net income-$373.9k-$373.9k2021
Operating income-$326.9k-$326.9k2021
Total assets$10.0k$10.0k2021
Liabilities$1.1M$1.1M2021
Equity-$1.1M-$1.1M2021
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Integrated Cannabis Solutions, Inc.’s revenue?
Integrated Cannabis Solutions, Inc. booked $0 in FY2021 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
GT Biopharma, Inc.32DUnited Health Products, Inc.26DPreveCeutical Medical Inc.——ENDRA Life Sciences Inc.25DExicure, Inc.31DVynleads, Inc.20DNeighbors
Broward →Key facts
CEOGene Caiazzo
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersCoconut Creek, FL
ExchangeOTC: IGPK
Employees1
IPO date1997-11-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.